Different responses of macrophages to smooth and rough Brucella spp.: relationship to virulence

scientific article published on April 2004

Different responses of macrophages to smooth and rough Brucella spp.: relationship to virulence is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/IAI.72.4.2429-2433.2004
P932PMC publication ID375206
P698PubMed publication ID15039375

P2093author name stringMaría P Jiménez de Bagüés
Antoine Gross
Jacques Dornand
Annie Terraza
P2860cites workChemokine receptors and their role in inflammation and infectious diseasesQ28144282
Identification of Brucella suis genes affecting intracellular survival in an in vitro human macrophage infection model by signature-tagged transposon mutagenesisQ30839901
Identification of the perosamine synthetase gene of Brucella melitensis 16M and involvement of lipopolysaccharide O side chain in Brucella survival in mice and in macrophages.Q31994658
Identification and characterization of the Brucella abortus phosphoglucomutase gene: role of lipopolysaccharide in virulence and intracellular multiplicationQ33591975
Transposon-derived Brucella abortus rough mutants are attenuated and exhibit reduced intracellular survivalQ33751418
Expression and bactericidal activity of nitric oxide synthase in Brucella suis-infected murine macrophages.Q33752010
Genetic characterization of a Tn5-disrupted glycosyltransferase gene homolog in Brucella abortus and its effect on lipopolysaccharide composition and virulenceQ34001337
The outer membrane of Brucella ovis shows increased permeability to hydrophobic probes and is more susceptible to cationic peptides than are the outer membranes of mutant rough Brucella abortus strainsQ34002596
Constitutive and inducible expression of green fluorescent protein in Brucella suis.Q34002884
Effects of opsonization and gamma interferon on growth of Brucella melitensis 16M in mouse peritoneal macrophages in vitroQ34003056
Smooth and rough lipopolysaccharide phenotypes of Brucella induce different intracellular trafficking and cytokine/chemokine release in human monocytesQ34228588
Rough lipopolysaccharide from Brucella abortus and Escherichia coli differentially activates the same mitogen-activated protein kinase signaling pathways for tumor necrosis factor alpha in RAW 264.7 macrophage-like cellsQ34258360
Effects of cytokines on intracellular growth of Brucella abortus.Q34521159
Live Brucella spp. fail to induce tumor necrosis factor alpha excretion upon infection of U937-derived phagocytes.Q34546937
Nramp1 is not a major determinant in the control of Brucella melitensis infection in miceQ34581384
Role of the Brucella suis lipopolysaccharide O antigen in phagosomal genesis and in inhibition of phagosome-lysosome fusion in murine macrophagesQ34714844
Identification of seven surface-exposed Brucella outer membrane proteins by use of monoclonal antibodies: immunogold labeling for electron microscopy and enzyme-linked immunosorbent assayQ35109089
Brucella-Salmonella lipopolysaccharide chimeras are less permeable to hydrophobic probes and more sensitive to cationic peptides and EDTA than are their native Brucella sp. counterpartsQ35614226
Protective immunity to Brucella ovis in BALB/c mice following recovery from primary infection or immunization with subcellular vaccinesQ35773419
Structure of the O-chain of the phenol-phase soluble cellular lipopolysaccharide of Yersinia enterocolitica serotype O:9.Q36592150
Lipopolysaccharide (LPS) from Brucella abortus is less toxic than that from Escherichia coli, suggesting the possible use of B. abortus or LPS from B. abortus as a carrier in vaccinesQ36942941
Prophylaxis or treatment of experimental brucellosis with interleukin-1Q36963615
Penetration and intracellular growth of Brucella abortus in nonphagocytic cells in vitroQ36985858
Killing of Brucella abortus by bovine serum.Q37002576
O antigen and lipid A phosphoryl groups in resistance of Salmonella typhimurium LT-2 to nonoxidative killing in human polymorphonuclear neutrophilsQ37007295
In vitro Brucella suis infection prevents the programmed cell death of human monocytic cellsQ39513799
Deletion of wboA enhances activation of the lectin pathway of complement in Brucella abortus and Brucella melitensisQ39521175
Interactions between Brucella melitensis and human phagocytes: bacterial surface O-Polysaccharide inhibits phagocytosis, bacterial killing, and subsequent host cell apoptosisQ39741598
The outer membranes of Brucella spp. are resistant to bactericidal cationic peptidesQ39822692
Studies on the mechanism of bacterial resistance to complement-mediated killing and on the mechanism of action of bactericidal antibodyQ39839146
Brucellacidal activity of human and bovine polymorphonuclear leukocyte granule extracts against smooth and rough strains of Brucella abortusQ40167985
High levels of nitric oxide production decrease early but increase late survival of Brucella abortus in macrophagesQ40768344
A beneficial aspect of a CB1 cannabinoid receptor antagonist: SR141716A is a potent inhibitor of macrophage infection by the intracellular pathogen Brucella suis.Q40891740
Identification of the A and M antigens of Brucella as the O-polysaccharides of smooth lipopolysaccharidesQ41518824
A two-component regulatory system playing a critical role in plant pathogens and endosymbionts is present in Brucella abortus and controls cell invasion and virulence.Q47694537
Heat-killed Brucella abortus induces TNF and IL-12p40 by distinct MyD88-dependent pathways: TNF, unlike IL-12p40 secretion, is Toll-like receptor 2 dependentQ47745245
Control of IL-12 and IFN-gamma production in response to live or dead bacteria by TNF and other factorsQ47756992
Nitric oxide production in human macrophagic cells phagocytizing opsonized zymosan: direct characterization by measurement of the luminol dependent chemiluminescence.Q47915703
Entry and intracellular localization of Brucella spp. in Vero cells: fluorescence and electron microscopyQ68365222
The structure of the lipopolysaccharide O-chain (M antigen) and polysaccharide B produced by Brucella melitensis 16MQ69022088
Evaluation of vaccines and of antigen therapy in a mouse model for Brucella ovisQ70545779
Conjugative transfer and in vitro/in vivo stability of the broad-host-range IncP R751 plasmid in Brucella sppQ70651864
Mechanisms of binding of Brucella abortus to mononuclear phagocytes from cows naturally resistant or susceptible to brucellosisQ72756568
Fundamentals of host immune response against Brucella abortus: what the mouse model has revealed about control of infectionQ78468297
P433issue4
P407language of work or nameEnglishQ1860
P304page(s)2429-2433
P577publication date2004-04-01
P1433published inInfection and ImmunityQ6029193
P1476titleDifferent responses of macrophages to smooth and rough Brucella spp.: relationship to virulence
P478volume72

Reverse relations

cites work (P2860)
Q93102945A Cellular Model of Infection with Brucella melitensis in Ovine Macrophages: Novel Insights for Intracellular Bacterial Detection
Q58581532A Mutation in the Gene Alters the Physicochemical Properties of the Bacterial Cell Wall and Reduces Survival inside
Q40203141A safe and molecular-tagged Brucella canis ghosts confers protection against virulent challenge in mice
Q40607020Activation of bovine neutrophils by Brucella spp.
Q30834268Advancement of knowledge of Brucella over the past 50 years
Q37191746Analysis of ten Brucella genomes reveals evidence for horizontal gene transfer despite a preferred intracellular lifestyle
Q49967391Brucella Lipopolysaccharide and pathogenicity: the core of the matter
Q34601987Brucella abortus rough mutants induce macrophage oncosis that requires bacterial protein synthesis and direct interaction with the macrophage.
Q38508267Brucella melitensis, B. neotomae and B. ovis elicit common and distinctive macrophage defense transcriptional responses
Q91987521Brucella ovis mutant in ABC transporter protects against Brucella canis infection in mice and it is safe for dogs
Q42633862Brucella suis prevents human dendritic cell maturation and antigen presentation through regulation of tumor necrosis factor alpha secretion
Q34742721Brucella: a pathogen without classic virulence genes.
Q36755736Brucellosis vaccines: assessment of Brucella melitensis lipopolysaccharide rough mutants defective in core and O-polysaccharide synthesis and export
Q33497936Caspase-2 mediated apoptotic and necrotic murine macrophage cell death induced by rough Brucella abortus
Q47840678Characterization of possible correlates of protective response against Brucella ovis infection in rams immunized with the B. melitensis Rev 1 vaccine
Q44086339Derivation of rough attenuated variants from smooth virulent Aeromonas hydrophila and their immunogenicity in fish.
Q44131041Differential expression of inflammatory and immune response genes in rams experimentally infected with a rough virulent strain of Brucella ovis
Q37085253Efficient production of pronuclear embryos in breeding and nonbreeding season for generating transgenic sheep overexpressing TLR4
Q27334495Entrance and survival of Brucella pinnipedialis hooded seal strain in human macrophages and epithelial cells
Q34995443Establishment of systemic Brucella melitensis infection through the digestive tract requires urease, the type IV secretion system, and lipopolysaccharide O antigen
Q34721256Evaluation of protection afforded by Brucella abortus and Brucella melitensis unmarked deletion mutants exhibiting different rates of clearance in BALB/c mice
Q39985225Evidence of Brucella abortus OPS dictating uptake and restricting NF-kappaB activation in murine macrophages.
Q40381512High susceptibility of human dendritic cells to invasion by the intracellular pathogens Brucella suis, B. abortus, and B. melitensis.
Q38110546Host-Brucella interactions and the Brucella genome as tools for subunit antigen discovery and immunization against brucellosis
Q35946874Improved immunogenicity of a vaccination regimen combining a DNA vaccine encoding Brucella melitensis outer membrane protein 31 (Omp31) and recombinant Omp31 boosting
Q52601690Inactivation of formyltransferase (wbkC) gene generates a Brucella abortus rough strain that is attenuated in macrophages and in mice.
Q42909728Interaction of Brucella suis and Brucella abortus rough strains with human dendritic cells.
Q37579682Lon Mutant of Brucella abortus Induces Tumor Necrosis Factor-Alpha in Murine J774.A1 Macrophage
Q38330161Mimicking microbial strategies for the design of mucus-permeating nanoparticles for oral immunization
Q56768285Monocyte-derived macrophages from Zebu (Bos taurus indicus) are more efficient to control Brucella abortus intracellular survival than macrophages from European cattle (Bos taurus taurus)
Q37592524Pathogenesis of bovine brucellosis.
Q42779049Proinflammatory caspase-2-mediated macrophage cell death induced by a rough attenuated Brucella suis strain
Q33883263Protective properties of rifampin-resistant rough mutants of Brucella melitensis
Q33769058Regulation of the mitogen-activated protein kinases by Brucella spp. expressing a smooth and rough phenotype: relationship to pathogen invasiveness.
Q90542419Swine brucellosis: current perspectives
Q40097780Systems Biology Analysis of Temporal In vivo Brucella melitensis and Bovine Transcriptomes Predicts host:Pathogen Protein-Protein Interactions
Q34369289The evolution of chronic infection strategies in the alpha-proteobacteria.
Q39368244The virB-encoded type IV secretion system is critical for establishment of infection and persistence of Brucella ovis infection in mice.
Q33388539Thrombotic thrombocytopenic purpura in a case of brucellosis
Q54217709Tissue distribution and cell tropism of Brucella canis in naturally infected canine foetuses and neonates.
Q37035400Virulence factors in brucellosis: implications for aetiopathogenesis and treatment.